Jasper Therapeutics, Inc. (JSPRW)
↓ Download CSVKey ratios (FY2025)
-1826.1%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | $41.63M | $34.27M | — | — | — | — | — |
| Operating Income | -$83.88M | -$76.24M | -$68.86M | -$51.20M | -$36.83M | -$20.68M | $2.90M |
| Net Income | -$75.80M | -$71.27M | -$64.47M | -$37.69M | -$30.64M | -$31.67M | — |
| EPS (Diluted) | $-3.95 | $-4.89 | $-6.18 | $-10.33 | $-2.69 | — | — |
| Total Assets | $35.78M | $79.90M | $94.89M | $48.36M | $93.65M | $23.36M | $101.69M |
| Total Liabilities | $31.63M | $18.23M | $16.45M | $12.37M | $24.14M | $14.65M | $10.85M |
| Shareholders' Equity | $4.15M | $61.67M | $78.44M | $35.99M | $69.52M | -$35.13M | -$4.73M |
| Cash & Equivalents | $28.69M | $71.64M | $86.89M | $38.25M | $84.70M | $19.84M | $1.21M |
| Operating Cash Flow | -$77.16M | -$62.60M | -$52.07M | -$45.86M | -$33.68M | -$18.27M | — |
| Shares Outstanding | 28.00M | 15.02M | 11.16M | 3.80M | 37.86M | 2.77M | — |